These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11432979)

  • 21. Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells.
    Ill-Raga G; Ramos-Fernández E; Guix FX; Tajes M; Bosch-Morató M; Palomer E; Godoy J; Belmar S; Cerpa W; Simpkins JW; Inestrosa And NC; Muñoz FJ
    J Alzheimers Dis; 2010; 22(2):641-52. PubMed ID: 20858976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells.
    Fonseca AC; Ferreiro E; Oliveira CR; Cardoso SM; Pereira CF
    Biochim Biophys Acta; 2013 Dec; 1832(12):2191-203. PubMed ID: 23994613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains.
    Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS
    Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKCε deficits in Alzheimer's disease brains and skin fibroblasts.
    Khan TK; Sen A; Hongpaisan J; Lim CS; Nelson TJ; Alkon DL
    J Alzheimers Dis; 2015; 43(2):491-509. PubMed ID: 25125477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
    J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
    Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
    Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pen-2 overexpression induces Aβ-42 production, memory defect, motor activity enhancement and feeding behavior dysfunction in NSE/Pen-2 transgenic mice.
    Nam SH; Seo SJ; Goo JS; Kim JE; Choi SI; Lee HR; Hwang IS; Jee SW; Lee SH; Bae CJ; Park JY; Kim HS; Shim SB; Hwang DY
    Int J Mol Med; 2011 Dec; 28(6):961-71. PubMed ID: 21822534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
    Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
    J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciproxifan improves cholinergic transmission, attenuates neuroinflammation and oxidative stress but does not reduce amyloid level in transgenic mice.
    Mani V; Jaafar SM; Azahan NSM; Ramasamy K; Lim SM; Ming LC; Majeed ABA
    Life Sci; 2017 Jul; 180():23-35. PubMed ID: 28501482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
    Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA
    J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
    Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
    Pappolla MA; Chyan YJ; Omar RA; Hsiao K; Perry G; Smith MA; Bozner P
    Am J Pathol; 1998 Apr; 152(4):871-7. PubMed ID: 9546346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.